Rare diseases, defined in the U.S. as conditions affecting fewer than 200,000 people, can take years, if not decades, to ...

Newborn babies admitted to the hospital's neonatal intensive care unit (NICU) rely on the quick decisions and rapid action of the medical team responsible for them. DNA testing is critical to ...

Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc.

GeneDX is set to launch ultrarapid whole genome sequencing (WGS) for neonatal and paediatric patients in intensive care units (NICU and PICU). According to the genetic testing company, the ...

Miami University’s Center for Bioinformatics and Functional Genomics (CBFG) has become one of the first institutions in the region to acquire the PacBio VEGA Benchtop System — a cutting-edge DNA ...

Researchers developed a reverse translation method that converts protein sequences into DNA, allowing standard DNA sequencers ...

Next-generation DNA sequencing (NGS)—the same technology which is powering the development of tailor-made medicines, cancer diagnostics, infectious disease tracking, and gene research—could become a ...

Researchers built an open tool to handle complex genome sequencing data, offering automated quality control, improved variant ...

The genome is more than a linear code; it is a dynamic structure whose three-dimensional folding dictates how genes are regulated. Traditional sequencing technologies capture base-level variation but ...